With support from a $2.5 million NIH grant, UB chemist David Heppner is trying to answer key questions about the time-consuming and costly drug discovery process.
RIA scientists aim to identify targets for new drug therapies to fight addiction by studying the role of fatty acid binding proteins (FABPs) in the brain’s endocannabinoid system.